Aditum Bio & Leads Biolabs Form Oblenio Bio for Autoimmune Disorder
07 Nov 2024 //
PR NEWSWIRE
Leads Biolabs Gets FDA Orphan Drug Status for LBL-034 in Myeloma
06 Nov 2024 //
PR NEWSWIRE
Leads Biolabs Unveils Preclinical Data On LBL-047 At EULAR 2024 Congress
17 Jun 2024 //
PR NEWSWIRE
Leads Biolabs` LBL-024 Shows Outstanding Phase II Anti-PD-L1/4-1BB Results
02 Jun 2024 //
PR NEWSWIRE
Leads Gets Nod For Bispecific Antibody LBL-024 Pivotal Trial
30 Apr 2024 //
PR NEWSWIRE
The U.S. FDA Approved the Ph I/II Clinical Trial Application to Evaluate LBL-033
16 Jun 2023 //
PR NEWSWIRE